(What I think is interesting is where this article appears, and its 
length.  That the DSM discussion should appear on a business site 
underscores the potential pharma and professional stakes.  When asked 
about outside scrutiny, Darrell Regier said: "It really isn't 
possible to identify what kind of outside group would have the 
expertise and range of discipline and disorders we're covering to do 
that kind of outside review."   That seems circular and 
self-sustaining to me.  Sylvia)

http://www.businessweek.com/news/2012-01-27/psychiatric-group-push-to-redefine-mental-illness-sparks-revolt.html



Powered by LSoft's LISTSERV(R) list management software